Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-3%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$44.4B
AUM Growth
+$1.2B
(+2.8%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281
Top Buys
| 1 |
Broadcom
AVGO
|
+$410M |
| 2 |
Salesforce
CRM
|
+$397M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$351M |
| 4 |
Boston Scientific
BSX
|
+$348M |
| 5 |
Intuitive Surgical
ISRG
|
+$286M |
Top Sells
| 1 |
Visa
V
|
+$575M |
| 2 |
Eli Lilly
LLY
|
+$532M |
| 3 |
Meta Platforms (Facebook)
META
|
+$386M |
| 4 |
Progressive
PGR
|
+$357M |
| 5 |
Lam Research
LRCX
|
+$271M |
Sector Composition
| 1 | Technology | 25.88% |
| 2 | Healthcare | 15.37% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLN
2201
Silence Therapeutics
SLN
$254M
| $139K | ﹤0.01% |
49,200
-49,600
| -50% | -$140K |
|
2202
Blue Foundry Bancorp
BLFY
$203M
| $138K | ﹤0.01% |
15,000
+2,500
| +20% | +$23K |
|
2203
ZimVie
ZIMV
$533M
| $136K | ﹤0.01% |
12,600
-200
| -2% | -$2.16K |
|
|
SOHU
2204
Sohu.com
SOHU
$483M
| $133K | ﹤0.01% |
10,100
-100
| -1% | -$1.32K |
|
2205
Tango Therapeutics
TNGX
$758M
| $133K | ﹤0.01% |
97,000
+70,800
| +270% | +$97K |
|
2206
Newmark Group
NMRK
$3.32B
| $133K | ﹤0.01% |
+10,900
| New | +$133K |
|
|
TRVG
2207
trivago
TRVG
$229M
| $132K | ﹤0.01% |
32,196
-2,800
| -8% | -$11.5K |
|
2208
PetMed Express
PETS
$58.9M
| $130K | ﹤0.01% |
31,100
-12,900
| -29% | -$54.1K |
|
2209
Village Farms International
VFF
$287M
| $129K | ﹤0.01% |
212,700
+19,700
| +10% | +$11.9K |
|
2210
NextNav
NN
$2.1B
| $128K | ﹤0.01% |
+10,500
| New | +$128K |
|
2211
Omeros
OMER
$287M
| $127K | ﹤0.01% |
15,500
-23,300
| -60% | -$192K |
|
2212
Lifestance Health
LFST
$2.18B
| $127K | ﹤0.01% |
19,000
-5,800
| -23% | -$38.6K |
|
2213
Itaú Unibanco
ITUB
$76B
| $126K | ﹤0.01% |
+22,900
| New | +$126K |
|
2214
RE/MAX Holdings
RMAX
$194M
| $125K | ﹤0.01% |
14,900
-2,400
| -14% | -$20.1K |
|
2215
Stagwell
STGW
$1.43B
| $123K | ﹤0.01% |
+20,400
| New | +$123K |
|
2216
Enviri
NVRI
$938M
| $122K | ﹤0.01% |
18,400
-5,600
| -23% | -$37.2K |
|
2217
Precigen
PGEN
$1.24B
| $122K | ﹤0.01% |
81,700
-10,900
| -12% | -$16.2K |
|
2218
Pacific Biosciences
PACB
$375M
| $121K | ﹤0.01% |
102,500
-65,400
| -39% | -$77.2K |
|
2219
Arhaus
ARHS
$1.61B
| $121K | ﹤0.01% |
13,900
-1,200
| -8% | -$10.4K |
|
|
RAPP
2220
Rapport Therapeutics
RAPP
$1.15B
| $120K | ﹤0.01% |
+12,000
| New | +$120K |
|
|
OKUR
2221
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.6M
| $119K | ﹤0.01% |
27,628
+13,400
| +94% | +$57.6K |
|
2222
Amprius Technologies
AMPX
$962M
| $118K | ﹤0.01% |
44,100
-1,600
| -4% | -$4.29K |
|
2223
Xperi
XPER
$284M
| $117K | ﹤0.01% |
15,100
+600
| +4% | +$4.63K |
|
|
NESR
2224
National Energy Services Reunited Corp. Ordinary Shares
NESR
$958M
| $116K | ﹤0.01% |
15,700
+1,500
| +11% | +$11K |
|
2225
Reservoir Media
RSVR
$518M
| $115K | ﹤0.01% |
15,100
-2,100
| -12% | -$16K |
|